Freezor® MAX 239F3Recalls & reported problems
Medtronic, Inc. · CATHETER 239F3 FREEZOR MAX3 MED BLUE 9F · Class 3
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00643169504905), received between Jun 9, 2017 and Jun 27, 2019 — classified as 3 injuries.
1 other recall cover devices cleared under the same FDA submission (P100010); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
Patient problems
- Low Blood Pressure/ Hypotension1
- Pericardial Effusion1
- ST Segment Depression1
- ST Segment Elevation1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryJun 27, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT PRIOR TO A CRYO ABLATION PROCEDURE, ST ELEVATION WAS OBSERVED. MEDICATION WAS ADMINISTERED WITH RESOLVE. THE CASE WAS COMPLETED WITH CRYO. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: ST Segment Elevation
MAUDE report 8741162 ↗InjuryFeb 6, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A CRYO ABLATION PROCEDURE, THE PATIENT EXPERIENCED A "DROP IN ST LEVEL". CORONARY ANGIOGRAPHY (CAG) INDICATED THAT THERE WAS NO STENOSIS, BUT THE CONTRAST MEDIA DID NOT FLOW NORMALLY. NITROGLYCERIN WAS THEN ADMINISTERED WITH RESOLVE. IT WAS NOTED THAT THE ST DEPRESSION RECOVERED. THE CASE WAS COMPLETED WITH CRYO. HOSPITALIZATION WAS NOT EXTENDED AS A RESULT OF THE EVENT. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: ST Segment Depression
MAUDE report 7245636 ↗InjuryJun 9, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT FOLLOWING A COMPLETED CRYO ABLATION PROCEDURE USING AN ELECTROPHYSIOLOGY (EP) CATHETER AND A COMPETITOR CATHETER, THE PATIENT¿S BLOOD PRESSURE DECLINED AND A PERICARDIAL EFFUSION WAS CONFIRMED. DRAINAGE WAS PERFORMED. IT WAS FURTHER REPORTED THAT THE PATIENTS CONDITION WAS ¿GOOD¿. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Low Blood Pressure/ Hypotension; Pericardial Effusion
MAUDE report 6630209 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P100010. One submission often covers many models, so check the product and lot details in each record.
- Z-0149-2012 · Aug 29, 2011 · TerminatedMedtronic Arctic Front Catheter, Sterile EO, Medtronic CryoCath LP, Kirkland, Quebec, H9H 5 H3, Canada, Model 2AF282 and 2AF231 ( not distributed in US) Product Usage: The Medtr
Other Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation devices
- TactiCath™ A-TCSE-DFSt. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation1 recall23 deaths923 reports
- TactiCath™ PN-004075St. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation7 deaths338 reports
- TactiFlex™ Sensor Enabled™ A-TFSE-DFSt. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation1 recall6 deaths241 reports
- TactiCath™ A-TCSE-FJSt. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation1 recall3 deaths174 reports
- Sphere-9™ Catheter AFR-00001Medtronic, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation1 recall3 deaths147 reports
- TactiCath™ A-TCSE-DSt. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation2 deaths175 reports
- TactiSys™ PN-004400St. Jude Medical, Inc. · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation1 recall125 reports
- QDOT MICRO D139402Biosense Webster Inc · Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation3 deaths171 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page